Vishwajeet Singh

Vishwajeet Singh (born 8 November 1991) is an Indian cricketer. He made his List A debut for Jammu & Kashmir in the 2016–17 Vijay Hazare Trophy on 4 March 2017. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Vishwajeet Singh', query time: 0.01s Refine Results
  1. 1
    A Review of Congenital Malformations among Live-born Neonates at a Tertiary Care Hospital in North India

    A Review of Congenital Malformations among Live-born Neonates at a Tertiary Care Hospital in North India by Vishwajeet Singh, Priyanka Gupta, Vivek, Ravindranath Mandal Ravi

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade

    Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade by Sunny Goel, Rahul J. Sinha, Ved Bhaskar, Ruchir Aeron, Ashish Sharma, Vishwajeet Singh

    Published 2019-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Understanding out-of-pocket expenditure in India: a systematic review

    Understanding out-of-pocket expenditure in India: a systematic review by Sagarika Kamath, Jeffin Maliyekkal, S. Elstin Anbu Raj, R. J. Varshini, Helmut Brand, Andria Sirur, Vishwajeet Singh, Vidya Prabhu, Kumar Sumit, Rajesh Kamath

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Spine Injuries Sustained After Falls While Crossing the U.S.-Mexico Border

    Spine Injuries Sustained After Falls While Crossing the U.S.-Mexico Border by Hannah R. Riva, Michael M. Polmear, Cyrena Petersen, June Y. Guillet, Taylor M. Yong, Adam H. Adler, Rajiv Rajani, Vishwajeet Singh, David Chin Sing Wang

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India

    Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India by Sneh Bhargave, Vinod Sharma, Babita Kataria, Atul Batra, Deepam Pushpam, Aparna Sharma, Raja Pramanik, Prabhat S. Malik, Ranjit. K. Sahoo, Sachin Khurana, Vishwajeet Singh, Sameer Bakhshi, Atul Sharma, Lalit Kumar, Akash Kumar

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: